SureTrader SureTrader
Home > Boards > US Listed > Medical - Equipment >

Edwards Life Sciences LLC (EW)

Add EW Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/26/2016 4:09:06 AM - Followers: 5 - Board type: Free - Posts Today: 1

What Edwards Lifesciences Does
Edwards Lifesciences partners with physicians to innovate products designed to help patients live longer, healthier and more productive lives. We focus on medical technologies that address large and growing patient populations in which there are significant unmet clinical needs, such as structural heart disease and critical care monitoring.

Our technologies are categorized into our four business units - heart valve therapy, critical care, cardiac surgery systems and vascular - each with a rich history and unique patient focus.

Heart Valve Therapy
Since developing the first heart valve in 1958, we have continued to meaningfully advance heart valve therapy and, more than 50 years later, we remain the global leader in this field. Our offerings include tissue replacement heart valves and valve repair products, such as those marketed under the Carpentier-Edwards, Cosgrove-Edwards, Edwards Prima Plus, Edwards SAPIEN, Magna and PERIMOUNT brands. In addition, our new INTUITY aortic valve system is currently being studied in a European clinical trial.

We also lead the development of new investigative technologies designed for the non-surgical replacement of heart valves. We believe transcatheter valves hold great promise for patients considered high-risk for conventional valve replacement as this technology allows clinicians to deliver valves via a catheter, eliminating the need for traditional open-heart surgery. Our Edwards SAPIEN transcatheter heart valve has been commercially available in Europe since 2007 and is being studied in the U.S. PARTNER Trial, the world's first randomized clinical trial of a transcatheter heart valve. Our Edwards SAPIEN XT valve, the second commercially available transcatheter valve in the Edwards SAPIEN product portfolio, is currently being studied in Japan's first clinical trial of a transcatheter valve. We are the only company to commercialize both transfemoral and transapical transcatheter aortic valve systems.

Critical Care
We have been advancing critical care monitoring for more than 40 years, following the development of the Swan-Ganz line of hemodynamic monitoring devices - the gold-standard for measuring cardiovascular performance during surgical procedures and in post-surgical intensive care settings. Our FloTrac system is used to gather some of the same patient information as the Swan-Ganz catheter less invasively. Our PreSep oximetry catheter is used in an emergency room protocol called early goal-directed therapy, which has been clinically proven to significantly reduce death and healthcare expenses related to severe sepsis - the number one cause of death in the non-coronary intensive care unit.

In late 2010, we launched our VolumeView set and EV1000 clinical platform in Europe. When used with the EV1000 clinical platform, the VolumeView set measures a patient's volumetric hemodynamic parameters and provides more clarity for clinicians treating critically ill patients. In addition, our EV1000 clinical platform integrates many of our sensors and catheters into one intuitive system. With a touch-screen monitor that displays a patient's physiologic status, as well as color-coded clinical targets and alerts, this new clinical platform is designed to simplify decision-making in the hospital environment.

We are also developing our GlucoClear blood glucose monitoring system for the hospital environment. This new technology is designed to provide an enhanced level of trending insight to enable clinicians to effectively implement glycemic control with the intent of improving patient outcomes.

Cardiac Surgery Systems
Our cardiac surgery systems product line offers market-leading technologies that facilitate on-pump cardiac surgery procedures through smaller incisions. The Edwards Lifesciences minimally invasive valve surgery system is comprised of soft tissue retractors, venous and arterial cannulae, aortic occlusion, venting, and coronary sinus catheters, as well as reusable instruments for performing minimally invasive valvular procedures.

We also offer the Edwards Protection Cannulae product line, which is a global leader in the cardiovascular cannulae market. This product line features differentiated products used for venous drainage, aortic perfusion, venting, and cardioplegia delivery. Additionally, our EMBOL-X intra aortic filtration system is designed to capture emboli released at both application and release of the aortic cross clamp during on-pump cardiac surgery.

Our vascular product line includes the industry-standard Fogarty clot management catheters, which have evolved to meet specialists' clinical needs over the past 45 years. Additional vascular products include Fogarty clamp inserts and spring clips for the gentle occlusion of vessels during surgery, as well as other balloon-tipped catheters.

Heart Valve Therapies

Pericardial Heart Valves

Heart Valve Repair

Cardiac Cannula

Other Tissue Valves

Minimal Incision
Valve Surgery

General Investor Relations
Phone: (949) 250-2806
Fax:  (949) 250-2248

David K. Erickson
Vice President, Investor Relations
Phone: (949) 250-6826

Laci Smith
Sr. Analyst, Investor Relations
Phone: (949) 250-2816

Proxy and Stock Certificate Questions
Computershare Shareholder Services
P.O. Box 43010
Providence, RI 02940
(800) 446-2617

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
EW News: Current Report Filing (8-k) 10/25/2016 04:24:42 PM
EW News: Edwards Lifesciences Reports Third Quarter Results 10/25/2016 04:15:00 PM
EW News: Edwards Lifesciences To Host Earnings Conference Call On October 25, 2016 10/12/2016 10:05:00 AM
EW News: Statement of Changes in Beneficial Ownership (4) 10/06/2016 04:30:09 PM
EW News: Statement of Changes in Beneficial Ownership (4) 10/04/2016 07:27:28 PM
News News Alert: Current Report Filing (8-k) 10/25/2016 04:24:42 PM
#264   Still think this is oversold. Best in class jones99 10/26/16 04:09:06 AM
#263   Saturday News.... Don 04/02/16 04:02:25 PM
#262   Inst % Owned = 95% TREND1 03/06/16 05:51:12 PM
#261   Float = 214.11M TREND1 03/06/16 05:50:14 PM
#260   EPS = 2.30 TREND1 03/06/16 05:48:55 PM
#259   EW DAY TREND1 03/06/16 05:48:04 PM
#258   SEE MY POSTS AT TREND1 03/06/16 05:39:54 PM
#257   Anybody following EW? Where are we heading Phaeton 05/23/14 06:16:15 PM
#255   I'm out of this one for now. Glad robtewms 04/14/14 07:14:16 PM
#254   fantastic move this morning.......... Belek 04/14/14 11:25:33 AM
#253   not sure about that, EW has a 50/200ema Belek 03/10/14 01:06:25 PM
#252   Thanks for sharing. In the past, outperform is robtewms 03/10/14 12:08:18 PM
#251   Edwards Life Sciences u[graded this morning to Outperform Belek 03/10/14 10:37:47 AM
#250   Thanks for sentiment. I like this company, but robtewms 03/06/14 04:42:56 PM
#249   looks like EW on a upward trajectory for Belek 03/06/14 12:51:55 AM
#248   Boom! Medtronic Corevalve early approval granted by the RealGenius 01/18/14 08:29:33 PM
#247   This stock has been doing well in my robtewms 10/19/13 12:33:21 PM
#246   Can you point out the interesting parts for robtewms 07/16/13 12:33:51 PM
#245   Goldman-Sachs Global-Healthcare-Conference ECole 07/16/13 06:11:59 AM
#244   I'm a new investor. What happened with knock-off? robtewms 07/09/13 07:20:36 PM
#243   Look at ICU Medicals FloTrac knockoff. This could hurt Texstar 02/01/13 12:22:25 AM
#242   TAVI: Mixed results for Edwards' Sapien valve in THESTCOKHUNTER 11/05/12 11:11:07 PM
#241   Edwards Lifesciences (NYSE:EW) reported EPS of $0.58 in THESTCOKHUNTER 11/04/12 08:56:16 AM
#240   there is interest,we just keep to ourselves, ihub THESTCOKHUNTER 10/24/12 10:37:31 PM
#239   well, time to buy EW??????????? THESTCOKHUNTER 10/24/12 01:32:10 PM
#238   EW, another guidance hit m177 10/09/12 10:00:35 AM
#237   I can't understand why there is no interest dfeickeesq 06/26/12 07:17:41 AM
#236   I believe that this is a likely split dfeickeesq 06/18/12 07:47:10 AM
#235   I purchase this one on the low point, DrMG 02/21/12 06:20:17 PM
#234   EW-stock analysis timvic 02/12/12 05:21:01 PM
#233   Edwards Lifesciences Corp (NYSE:EW) reported Q4 adjusted EPS THESTCOKHUNTER 02/05/12 09:17:37 AM
#232   ~ $EW ~ Earnings posted, pending or coming Penny Roger$ 02/05/12 03:16:37 AM
#231   hey Doc, any opinion here? bought some, but THESTCOKHUNTER 02/03/12 04:16:28 PM
#230   ok THESTCOKHUNTER 02/03/12 12:53:59 PM
#229   Not here. Busy with 2 of my own PoemStone 02/03/12 12:38:27 PM
#228   you still around THESTCOKHUNTER 02/03/12 12:24:31 PM
#227   Is this a good buying opportunity or what?? THESTCOKHUNTER 02/03/12 11:42:18 AM
#226   This stock treat me so well! DrMG 01/23/12 10:42:06 PM
#225   shooot man i miss the good re entree point. DrMG 11/24/11 05:53:21 PM
#224   Medtronic earnings this morning came out positive and dealorfx 11/22/11 08:31:44 AM
#223   A number of equity research firms have modified dealorfx 11/21/11 09:01:58 AM
#222   Potential Edwards Lifesciences (EW) Trade Has $57.28 Breakeven dealorfx 11/19/11 07:19:36 AM
#221   Now that was funny. Well not so funny cjstocksup 11/16/11 07:39:53 PM
#220   And I was thinking yesterday was maybe PoemStone 11/16/11 05:28:33 PM
#219   down $3.50 today, thats a biggee,,,market was fine dealorfx 11/16/11 05:24:32 PM
#218   Down a dollar today - no biggie. PoemStone 11/15/11 01:44:50 PM
#217   Edwards Lifesciences (EW) Showing Bearish Technicals But Could dealorfx 11/11/11 07:06:48 PM
#216   Edwards Lifesciences Crosses Below its 10-day MA (EW) dealorfx 11/09/11 06:46:41 PM
#215   Edwards Lifesciences heart valve study halted dealorfx 11/08/11 10:26:06 PM
#214   Nice, post & commentary. PoemStone 11/07/11 06:27:53 PM